We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com ...

Charles Schwab Investment Management Inc. lessened its stake in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 17.2% in the ...

Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...

Bank of New York Mellon Corp lowered its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 13.5% in the ...

As of 4 March at 10:19:35 am GMT-5. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

PLEASANTON, CA—Alan Mateo, a director at 10x Genomics, Inc. (NASDAQ:TXG), has recently increased his stake in the company.... In a turbulent market environment, 10X Genomics Inc (NASDAQ:TXG) ...

Cathie Wood's ARK ETFs have made a series of trades on Tuesday, April 9, 2024, as part of their regular portfolio adjustments. The ...